Archives

by in
Entry Author Date Location
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
Hologic Names New CEO, Cuts Deal With Icahn to Avoid Proxy Fight 12/09/13 Boston
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More 11/07/13 Boston
Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M 08/14/13 San Diego
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Intarcia Snags $210M to Push Implantable Device for Diabetes 11/15/12 Boston
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More 04/27/12 San Diego
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More 03/08/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Unlimited Abilities: A View from the MedtechVision Conference 09/27/11 San Francisco
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Bydureon FDA Deadline Set 08/10/11 San Diego
Amylin & Takeda Halt Obesity Drug Development 08/04/11 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Bydureon Sent Back to FDA 07/28/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News 07/28/11 San Diego
Page 1 of 6 next page »